Empaglifloz/Linaglip/Metformin
Brand name: Trijardy Xr
Rank #391 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$23.9M
Total Cost
28,001
Total Claims
$23.9M
Total Cost
747
Prescribers
$852
Cost per Claim
3,664
Beneficiaries
40,622
30-Day Fills
$32K
Avg Cost/Provider
37
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$23.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $23.9M total
🔎 Data Overview
Average cost of $6,511 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Empaglifloz/Linaglip/Metformin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Sheila Mercado | Endocrinology | Manati, PR | 1,239 | $815K |
| 2 | Dalitza Alvarez Valentin | Endocrinology | San Juan, PR | 647 | $649K |
| 3 | Naomi Collazo Gutierrez | Endocrinology | Manati, PR | 713 | $503K |
| 4 | Manuel Alegre-Hernandez | Endocrinology | San Juan, PR | 392 | $363K |
| 5 | Jorge Martinez | Endocrinology | Bayamon, PR | 253 | $297K |
| 6 | Samuel Padilla Rosa | Internal Medicine | Manati, PR | 360 | $296K |
| 7 | Daniela Dicenso | Internal Medicine | Miami, FL | 302 | $271K |
| 8 | Eleazar Flores | Family Practice | Baytown, TX | 298 | $268K |
| 9 | Coleen Schmidley | Nurse Practitioner | West Reading, PA | 245 | $257K |
| 10 | Paula Jeffs-Gonzalez | Endocrinology | Trujillo Alto, PR | 363 | $238K |
| 11 | Samayra Miranda Rodriguez | Endocrinology | Dorado, PR | 305 | $228K |
| 12 | Jamil Abouelhossen | Internal Medicine | Fajardo, PR | 290 | $222K |
| 13 | Rose Roman Torres | Endocrinology | Mayaguez, PR | 327 | $209K |
| 14 | Harish Thakkar | Internal Medicine | Sugar Land, TX | 162 | $205K |
| 15 | Luis Rivera | Internal Medicine | San Juan, PR | 260 | $204K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 388 | Linagliptin/Metformin Hcl (Jentadueto) | $24.3M | 33,018 |
| 389 | Ocrelizumab (Ocrevus) | $24.2M | 639 |
| 390 | Fenofibrate (Fenofibrate) | $24.2M | 670,936 |
| 391 | Empaglifloz/Linaglip/Metformin (Trijardy Xr) | $23.9M | 28,001 |
| 392 | Fluticasone Furoate (Arnuity Ellipta) | $23.7M | 74,825 |
| 393 | Lactulose (Lactulose) | $23.6M | 538,677 |
| 394 | Siponimod (Mayzent) | $23.5M | 2,195 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology